Q2 2014 Venture Fundraising Update

// Wiley Becker

August 5, 2014 -

Both Number of Funds and Capital Raised Continues Upward Trajectory

Capital Continues to be Highly Concentrated with a Small Number of Funds

Number of New Funds Also Increases, but Only Accounts for 8% of Total Capital Raised 

+ Read More

Entrepreneurs in the Academy: the Role of Entrepreneurship in Engineering Education at Research Universities

// Trevor Loy

July 23, 2014 -

Nearly twenty years ago, Dr. Tom Byers came to Stanford University with an audacious idea.  He believed that entrepreneurship education ought to be a fundamental part of the curriculum for every student in the fields of science, technology, engineering, and mathematics (STEM).  Moreover, he argued that rigorous scholarly research on the entrepreneurial process should be a fundamental part of the broader academic mission of a research university.  To drive these ideas, he founded the Stanford Technology Ventures Program (STVP), and was joined a few years later by STVP Executive Director Tina Seelig.  


+ Read More

Q2 2014 Venture Exits Update

// Wiley Becker

July 23, 2014 - There were 97 US venture backed M&A transactions in Q2 2014 with $3.3B in disclosed deal value according to the Exit Poll report by Thomson Reuters and the NVCA.  Disclosed deal value on a rolling four quarter basis fell by 5% in spite of an 11% increase in the number of deals disclosed.  Consequently, the average M&A deal size fell 14% on a rolling four quarter basis to $174.4MM.  However, disclosed deal value depends highly on the composition of deals disclosed.  According to PitchBook, the median deal size is $150MM through Q2 2014 of 306 venture backed M&A exits globally (PitchBook Data, Inc. 2014).  Additionally, ten M&A exits have closed in 2014 at greater than $500MM valuations, while another 50 have closed in the $100-500MM range.
+ Read More

A Look Back at the Past 18 Months of IPO Activity in the Biotech/Pharma Market

// Monica Rivera Beam, PhD

July 23, 2014 - Since the first quarter of 2013, there has been continual talk and focus on the apparent “window of opportunity” for early stage biotechnology and pharmaceutical companies to go public. Let's take a look at 18 months of IPOs to provide a perspective on what types of companies have gone public, how venture capital firms and other early investors have benefited, and how the market in general has received these companies.
+ Read More

Managing the Little Things

// Zack Mansfield

June 25, 2014 - The role of a startup’s CEO is one which requires an insane amount of multi-tasking and focus.  One day you might be hammering out the intricacies of your product or having a customer conversation to validate product/market fit.  Then the next you’re taking meetings with insurance guys to make sure you have the right policies in place to protect your business.  Oh yeah, you’re also responsible for raising the capital needed to grow and, more often than not, you’re doing some kind of sales too. 
+ Read More

Best Practices for Establishing Your Client Services Team

// Kurt Ruesch

June 25, 2014 - Kurt Ruesch, Square 1 Bank Founder and Director of Client Services, offers quick thoughts and tips on establishing a client services team and fostering your service culture.
+ Read More